Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market
October 8, 2025
News
Strategic collaboration combines KYBORA’s global biopharma network with ACA Pharma’s 30–90 day Macau registration model to expedite access for rare disease and pediatric therapies in China. KYBORA and ACA Pharma…
READ MORE
KYBORA Welcomes Damien Villeneuve To The Team
June 1, 2021
News
KYBORA is pleased to announce that Damien Villeneuve has joined its team as a Senior Advisor for South East Asia.…
READ MORE
KYBORA GmbH welcomes Jean-Baptiste Duval to the team
May 13, 2021
News
KYBORA GmbH is pleased to announce that Jean-Baptiste Duval is joining its team as a Senior Advisor. Jean-Baptiste has worked…
READ MORE
KYBORA is moving to a new office in Princeton, NJ
April 13, 2021
News
We are pleased to announce that KYBORA is moving to a new office location on Witherspoon Street in Princeton, New…
READ MORE
KYBORA GmbH is pleased to announce the appointments of SASCHA BUCHER, ERIC DOULAT, and STEPHEN STEAD to its Board of Directors
March 18, 2021
News
BASEL, SWITZERLAND (PRWEB) MARCH 17, 2021 Alan Vanderborght, founder and Chief Executive Officer of KYBORA Group and Chairman of the Board…
READ MORE
KYBORA Appoints Jean CHATELLIER as Executive Vice President of KYBORA and, Managing Director and Member of the Board of Directors of its European Affiliate, KYBORA GmbH
March 18, 2021
News
PRINCETON, N.J., AND BASEL, SWITZERLAND (PRWEB) MARCH 17, 2021 Alan Vanderborght said, “I am thrilled to have Jean join our team.…
READ MORE
KYBORA Opens its First Fully Owned Affiliate, KYBORA GmbH in Basel, Switzerland
March 18, 2021
News
PRINCETON, N.J. (PRWEB) MARCH 16, 2021 Alan Vanderborght, Founder and CEO of KYBORA, said: “The opening of KYBORA GmbH is the…
READ MORE
KYBORA is attending Bio Partnering at JPM
December 8, 2020
News
KYBORA is attending Bio Partnering at JPM. We look forward to connecting with you there and show you how to…
READ MORE
KYBORA announces that Bayer Healthcare Pharmaceuticals has sold a PRV to argenx
November 23, 2020
Mergers and Acquisitions, News
KYBORA is pleased to announce that its client Bayer Healthcare Pharmaceuticals has sold a Priority Review Voucher (PRV) to argenx.
READ MORE
Russian Federation Pharma – March 2020 update
June 8, 2020
News
KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular…
READ MORE
KYBORA Sponsors the Bio Latin America Conference Again
May 30, 2020
News
KYBORA is happy to announce that it will sponsor the Bio Latin America Conference again this year. Taking place in…
READ MORE
Is China High Enough on Your Priority List?
May 28, 2020
News
“If you are a U.S. company that does not yet have a China strategy…you need to get moving or risk…
READ MORE
KYBORA successfully helps Stada license Xlucane to Bausch Health
May 6, 2020
News
KYBORA is pleased to announce that it has successfully helped its client STADA Arzneimittel AG license Xlucane – a Ranibizumab…
READ MORE
«
‹
6
7
8
9
›
TYPE & ENTER:
Close
